Squamous Cell Carcinoma
Conditions
Keywords
squamous cell carcinoma
Brief summary
Clinical research participation has historically been heavily biased toward specific demographics. This study will invite several participants to gather a wide range of information on clinical trial experiences for squamous cell carcinoma patients. The aim of the study is to identify the factors that limit the ability of a person to enroll in, as well as complete a clinical trial for treatment of squamous cell carcinoma. People with squamous cell carcinoma who are invited to take part in clinical research will benefit from the analysis of the data.
Interventions
None listed
Sponsors
Power Life Sciences Inc.
Study design
Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Aged ≥ 18 years old * Confirmed diagnosis of squamous cell carcinoma * Subjects willing and able to comply with the protocol for the duration of the study including undergoing treatment and scheduled visits and examination.
Exclusion criteria
* Inability to provide written informed consent * Is pregnant, breastfeeding or expecting to conceive within the projected duration of the study * Enrolled in another research study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients who decide to enroll in a squamous cell carcinoma clinical trial | 3 months |
| Rate of patients who remain in squamous cell carcinoma clinical trial to trial completion | 12 months |
Countries
United States
Contacts
Primary ContactMichael B Gill
Outcome results
None listed